论文部分内容阅读
为了评估接受门静脉切除(PVR)的胰腺癌 患者并发症发生率、死亡率和总体生存情况。本研究前瞻性地调查了1983年10月至1995年8月间332例组织学诊断为胰腺癌并接受胰腺切除的患者资料。其中58例(17%)合并孤立的门静脉受累,并接受了连同PVR的胰腺切除。以同期接受不需PVR的治愈性胰腺切除患者作为对照。 手术方式包括胰十二指肠切除、全胰切除或远侧胰腺次全切除。两组患者手术时年龄和性别比相似。PVR组中38例行门静脉直接端端吻
To assess the incidence of complications, mortality and overall survival in patients undergoing portal vein resection (PVR) for pancreatic cancer. This study prospectively investigated the data of 332 patients with histologically diagnosed pancreatic cancer who underwent pancreatic resection between October 1983 and August 1995. Fifty-eight (17%) of them merged with isolated portal vein involvement and underwent pancreatic resection together with PVR. Patients who received curative pancreatectomy without PVR at the same time were used as controls. Surgical methods include pancreatoduodenectomy, pancreatectomy or subtotal pancreatic resection. The age and sex ratios at the time of surgery were similar in both groups. 38 patients in the PVR group had a direct portal vein kiss